Pfizer Inc (PFE-RM)

2,939.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    2,500.00/2,940.00
  • Day's Range:
    2,400.00 - 3,487.00
Trading near 52-week Low

Pfizer has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

PFE-RM Overview

Prev. Close
3,592
Day's Range
2,400-3,487
Revenue
7.41T
Open
3,379
52 wk Range
2,400-4,709
EPS
-
Volume
0
Market Cap
18.19T
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
747
P/E Ratio
-
Beta
-
1-Year Change
-26.69%
Shares Outstanding
5,610,895,801
Next Earnings Date
-
What is your sentiment on Pfizer?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Russia
  • ISIN:US7170811035

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average54.90 (+7.84% Upside)
High75
Low44
Price50.91
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • ᶜᴿᵞᴾᵀᴼ ᴵᴺᵛᴱˢᵀᴹᴱᴺᵀ ᴵˢ ᴬ ᴹᵁᴸᵀᴵᴾᴸᴱ ˢᵀᴿᴱᴬᴹ ᴼᶠ ᴵᴺᶜᴼᴹᴱ, ˢᴱᴺᴰ ᴬ ᴰᴵᴿᴱᶜᵀ ᴹᴱˢˢᴬᴳᴱ ᵀᴼ ᶠᴸᴼᴿᴱᴺᶜᴱ ᴶ ᵀᴴᴱᴼᴰᴼᴿᴱ ᴼᴺ ᶠᴬᶜᴱᴮᴼᴼᴷ. ᵀᴼ ᴱᴬᴿᴺ ᴹᴼᴺᴱᵞ ᵂᴱᴱᴷᴸᵞ ᵀᴴᴿᴼᵁᴳᴴ ᶜᴿᵞᴾᵀᴼᴵᴺᵛᴱˢᵀ ᴵᴺ ᶜᴿᵞᴾᵀᴼᶜᵁᴿᴿᴱᴺᶜᵞ ᴺᴼᵂ!
    0
    • Can Pfizer Surpass $70 Per Share? The answer is absolutely not! the CEO & other managers won't that happen.
      1
      • most of major drug stocks hit new high except Pfizer. that means Pfizer is totally manipulated by insiders.
        0
        • Glad to see how many comments here are indictments of Pfizer's actions involved with the mRNA vaxx. They are part of a global conspiracy to hide the risks associated with their product from the public while pushing for more EUA approvals, even for children. They need to be sued to hell.
          1
          • I hope this crash and everyone invested in this diabolic company get ruined for life. All the money should go to victims of the vaxx
            3
            • An uptrend of Pfizer is a trap, and when many buyers step in, the gates will close and George Soros will hunt them down.
              0
              • Ray,, its been a while, you changed your name but other than that everything looks about the same
                0
                • Pfizer is every buyer's nightmare.
                  2
                  • Pfizer was born to sell short. Making money is 99.99999%.
                    7
                    • good vaccine!
                      3